-
1
-
-
0030156357
-
Lutetium texaphyrin (PCI-0123): A near-infrared, water-soluble photosensitizes
-
Young, S.W., Woodburn, K.W., Wright, M., et al. (1996). Lutetium texaphyrin (PCI-0123): A near-infrared, water-soluble photosensitizes. Photochem. Photobiol. 63, 892-897.
-
(1996)
Photochem. Photobiol.
, vol.63
, pp. 892-897
-
-
Young, S.W.1
Woodburn, K.W.2
Wright, M.3
-
2
-
-
0029728513
-
Selective uptake of texaphyrins by atheromatous plaque
-
Woodburn, K.W., Young, S.W., Fan, Q., and Miller, R.A. (1996). Selective uptake of texaphyrins by atheromatous plaque. Proc. SPIE 2671, 62-71.
-
(1996)
Proc. SPIE
, vol.2671
, pp. 62-71
-
-
Woodburn, K.W.1
Young, S.W.2
Fan, Q.3
Miller, R.A.4
-
3
-
-
10544230084
-
Phase I photodynamic trial with lutetium texaphyrin (PCI-0123) in patients with metastatic cancer
-
Wieman, T.J., Fingar, V., Taber, S., et al. (1996). Phase I photodynamic trial with lutetium texaphyrin (PCI-0123) in patients with metastatic cancer. Photochem. Photobiol. 80S.
-
(1996)
Photochem. Photobiol.
-
-
Wieman, T.J.1
Fingar, V.2
Taber, S.3
-
4
-
-
0028216083
-
Preclinical evaluation of gadolinium (III) complex. A new paramagnetic contrast agent for magnetic resonance imaging
-
Young, S.W., Sidhu, M.K., Fan, Q., et al. (1994). Preclinical evaluation of gadolinium (III) complex. A new paramagnetic contrast agent for magnetic resonance imaging. Invest. Rad. 29, 330-338.
-
(1994)
Invest. Rad.
, vol.29
, pp. 330-338
-
-
Young, S.W.1
Sidhu, M.K.2
Fan, Q.3
-
5
-
-
0030013113
-
Gadolinium(III) texaphyrin: A tumor selective radiation sensitizer that is detectable by MRI
-
Young, S.W., Fan, Q., Harriman, A., et al. (1996). Gadolinium(III) texaphyrin: A tumor selective radiation sensitizer that is detectable by MRI. Proc. Natl. Acad. Sci. U.S.A. 93, 6610-6615.
-
(1996)
Proc. Natl. Acad. Sci. U.S.A.
, vol.93
, pp. 6610-6615
-
-
Young, S.W.1
Fan, Q.2
Harriman, A.3
-
6
-
-
0004980758
-
Phase I study of gadolinium texaphyrin as an MRI contrast and radiosensitizer agent
-
Rosenthal, D.I., Becerra, C.R., Nurenberg, P., et al. (1996). Phase I study of gadolinium texaphyrin as an MRI contrast and radiosensitizer agent. Proc. ASCO 15, 1663.
-
(1996)
Proc. ASCO
, vol.15
, pp. 1663
-
-
Rosenthal, D.I.1
Becerra, C.R.2
Nurenberg, P.3
-
7
-
-
33751386168
-
Synthesis and structural characterization of lanthanide(III) texaphyrins
-
Sessler, J.L., Mody, T.D., Hemmi, G.W., and Lynch, V. (1993). Synthesis and structural characterization of lanthanide(III) texaphyrins. Inorg. Chem. 32, 3175-3187.
-
(1993)
Inorg. Chem.
, vol.32
, pp. 3175-3187
-
-
Sessler, J.L.1
Mody, T.D.2
Hemmi, G.W.3
Lynch, V.4
-
8
-
-
84989479584
-
Growth and cell population kinetics of single and multiple KHT sarcomas
-
Rockwell, S., and Kallman, R.F. (1972). Growth and cell population kinetics of single and multiple KHT sarcomas. Cell Tissue Kinet. 5, 449-457.
-
(1972)
Cell Tissue Kinet.
, vol.5
, pp. 449-457
-
-
Rockwell, S.1
Kallman, R.F.2
-
9
-
-
0025193947
-
Chemical and physiological comparison of advanced atherosclerotic lesions of similar size and cholesterol content in cholesterolfed New Zealand white and Watanabe heritable hyperlipidemic rabbits
-
Nolle, C.J.M., Tercyak, A.M., Wu, H.M., and Small, D.M. (1990). Chemical and physiological comparison of advanced atherosclerotic lesions of similar size and cholesterol content in cholesterolfed New Zealand white and Watanabe heritable hyperlipidemic rabbits. Lab. Invest. 62, 213-222.
-
(1990)
Lab. Invest.
, vol.62
, pp. 213-222
-
-
Nolle, C.J.M.1
Tercyak, A.M.2
Wu, H.M.3
Small, D.M.4
-
10
-
-
0011319326
-
Atherosclerosis research
-
P.J. Manning, D.H. Ringler, and C.E. Newcomer (eds.). San Diego: Academic Press
-
Jayo, J.M., Schwenke, D.C., and Clarkson, T.B. (1994). Atherosclerosis research, in: The Biology of the Laboratory Rabbit. P.J. Manning, D.H. Ringler, and C.E. Newcomer (eds.). San Diego: Academic Press, pp. 367-380.
-
(1994)
The Biology of the Laboratory Rabbit
, pp. 367-380
-
-
Jayo, J.M.1
Schwenke, D.C.2
Clarkson, T.B.3
-
11
-
-
0029002352
-
Effect of density-gradients on binding of photosensitizing agents to plasma proteins
-
Woodburn, K., and Kessel, D. (1995). Effect of density-gradients on binding of photosensitizing agents to plasma proteins. Int. J. Biochem. Cell Biol. 27, 499-506.
-
(1995)
Int. J. Biochem. Cell Biol.
, vol.27
, pp. 499-506
-
-
Woodburn, K.1
Kessel, D.2
-
12
-
-
0000999389
-
Influence of drug and light regimens in determining PDT efficacy with lutetium texaphyrin
-
Woodburn, K.W., Young, S.W., and Miller, R.A. (1996). Influence of drug and light regimens in determining PDT efficacy with lutetium texaphyrin. Proc. SPIE. 2675, 172-178.
-
(1996)
Proc. SPIE.
, vol.2675
, pp. 172-178
-
-
Woodburn, K.W.1
Young, S.W.2
Miller, R.A.3
-
13
-
-
10544224431
-
Biological analysis of lutetium texaphyrin (PCI-0123)
-
Woodburn, K.W., Qing, F., Miles, D.R., Kessel, D., and Young, S.W. (1996). Biological analysis of lutetium texaphyrin (PCI-0123). Photochem. Photobiol. 80S, 63S.
-
(1996)
Photochem. Photobiol.
-
-
Woodburn, K.W.1
Qing, F.2
Miles, D.R.3
Kessel, D.4
Young, S.W.5
-
14
-
-
0006339988
-
Lutetium (III) texaphyrin: A novel photodynamic therapy agent
-
Mody, T.D., Wright, M., Linquist, V., et al. (1994). Lutetium (III) texaphyrin: A novel photodynamic therapy agent. Photochem. Photobiol. 59S, 37S.
-
(1994)
Photochem. Photobiol.
-
-
Mody, T.D.1
Wright, M.2
Linquist, V.3
-
15
-
-
0027446986
-
Photodynamic therapy in oncology: Mechanisms and clinical use
-
Pass, H.I. (1993). Photodynamic therapy in oncology: Mechanisms and clinical use. JNCI 85, 443-456.
-
(1993)
JNCI
, vol.85
, pp. 443-456
-
-
Pass, H.I.1
-
16
-
-
0002168981
-
Photosensitization
-
J.M. Isner and R.H. Clarke (eds.). New York: Raven Press
-
Spears, J.R. (1989). Photosensitization, in: Cardiovascular Laser Therapy. J.M. Isner and R.H. Clarke (eds.). New York: Raven Press, pp. 107-120.
-
(1989)
Cardiovascular Laser Therapy
, pp. 107-120
-
-
Spears, J.R.1
|